PNC Financial Services Group
TGTX icon

PNC Financial Services Group’s TG Therapeutics TGTX Stock Holding History

PNC Financial Services Group’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.93M Buy
89,646
+77,829
+659% +$3.19M ﹤0.01% 767
2026
Q1 		$393K Buy
11,817
+2,162
+22% +$64.4K ﹤0.01% 1856
2025
Q4 		$288K Sell
9,655
-1,421
-13% -$46.4K ﹤0.01% 2036
2025
Q3 		$400K Buy
11,076
+1,380
+14% +$45.5K ﹤0.01% 1802
2025
Q2 		$349K Buy
9,696
+677
+8% +$25.2K ﹤0.01% 1817
2025
Q1 		$356K Buy
9,019
+1,916
+27% +$64.5K ﹤0.01% 1771
2024
Q4 		$214K Sell
7,103
-1,269
-15% -$36.4K ﹤0.01% 2162
2024
Q3 		$196K Buy
8,372
+4,818
+136% +$105K ﹤0.01% 2196
2024
Q2 		$63.2K Buy
3,554
+1
+0% +$16 ﹤0.01% 2909
2024
Q1 		$54K Buy
3,553
+71
+2% +$1.13K ﹤0.01% 2959
2023
Q4 		$59.5K Sell
3,482
-61
-2% -$709 ﹤0.01% 2886
2023
Q3 		$29.6K Buy
3,543
+2,014
+132% +$28.1K ﹤0.01% 3215
2023
Q2 		$38K Sell
1,529
-75
-5% -$1.94K ﹤0.01% 3217
2023
Q1 		$24.1K Buy
1,604
+660
+70% +$10K ﹤0.01% 3408
2022
Q4 		$11.2K Sell
944
-400
-30% -$2.9K ﹤0.01% 3738
2022
Q3 		$8K Buy
1,344
+116
+9% +$761 ﹤0.01% 3850
2022
Q2 		$5K Buy
1,228
+82
+7% +$512 ﹤0.01% 4011
2022
Q1 		$10K Buy
1,146
+21
+2% +$243 ﹤0.01% 3834
2021
Q4 		$20K Sell
1,125
-1,174
-51% -$30.5K ﹤0.01% 3554
2021
Q3 		$76K Buy
2,299
+6
+0.3% +$186 ﹤0.01% 2811
2021
Q2 		$89K Buy
2,293
+1,233
+116% +$48.4K ﹤0.01% 2722
2021
Q1 		$51K Sell
1,060
-82
-7% -$3.94K ﹤0.01% 2973
2020
Q4 		$59K Buy
1,142
+137
+14% +$4.63K ﹤0.01% 2803
2020
Q3 		$27K Buy
+1,005
New +$23.1K ﹤0.01% 3079
2020
Q2 		– Sell
-1,000
Closed -$10K – 4053
2020
Q1 		$10K Hold
1,000
– – ﹤0.01% 3418
2019
Q4 		$11K Buy
+1,000
New +$7.6K ﹤0.01% 3501
2018
Q4 		– Sell
-600
Closed -$4K – 4175
2018
Q3 		$4K Hold
600
– – ﹤0.01% 3869
2018
Q2 		$8K Sell
600
-1,000
-63% -$13.8K ﹤0.01% 3757
2018
Q1 		$22K Buy
1,600
+1,000
+167% +$12.8K ﹤0.01% 3398
2017
Q4 		$4K Hold
600
– – ﹤0.01% 3910
2017
Q3 		$8K Hold
600
– – ﹤0.01% 3763
2017
Q2 		$6K Hold
600
– – ﹤0.01% 3760
2017
Q1 		$6K Hold
600
– – ﹤0.01% 3690
2016
Q4 		$2K Sell
600
-2,000
-77% -$11.7K ﹤0.01% 3859
2016
Q3 		$19K Sell
2,600
-210
-7% -$1.35K ﹤0.01% 3253
2016
Q2 		$17K Sell
2,810
-8
-0.3% -$65 ﹤0.01% 3349
2016
Q1 		$25K Buy
2,818
+4
+0.1% +$35 ﹤0.01% 3169
2015
Q4 		$35K Buy
2,814
+2,600
+1,215% +$32.8K ﹤0.01% 3011
2015
Q3 		$2K Sell
214
-1,993
-90% -$29.7K ﹤0.01% 4315
2015
Q2 		$36K Buy
2,207
+2,086
+1,724% +$33K ﹤0.01% 3213
2015
Q1 		$2K Hold
121
– – ﹤0.01% 4326
2014
Q4 		$2K Buy
+121
New +$1.58K ﹤0.01% 3830

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

PNC Financial Services Group's TGTX Position: Q2 2026 in Review

PNC Financial Services Group increased its TG Therapeutics (TGTX) stake by 659% in Q2 2026, buying an estimated $3.19M and bringing the position to 89,646 shares worth $4.93M. The position accounts for ﹤0.01% of the portfolio, ranked #767.

PNC Financial Services Group first reported a position in TGTX in Q4 2014 and has held it in 42 quarters since. 205 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • PNC Financial Services Group held 89,646 shares of TG Therapeutics worth $4.93M as of Q2 2026.
  • PNC Financial Services Group bought 77,829 TG Therapeutics shares in Q2 2026, an estimated $3.19M.
  • TG Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #767 holding.
  • PNC Financial Services Group first reported a position in TG Therapeutics in Q4 2014 and has held it in 42 quarters since.
  • 205 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.